138 related articles for article (PubMed ID: 35117923)
1. Expression of biogenesis of ribosomes BRX1 is associated with malignant progression and prognosis in colorectal cancer.
Ge J; Huang X; Wang P; Lu C
Transl Cancer Res; 2020 Sep; 9(9):5595-5602. PubMed ID: 35117923
[TBL] [Abstract][Full Text] [Related]
2. BRIX1 promotes ribosome synthesis and enhances glycolysis by selected translation of GLUT1 in colorectal cancer.
Jiang C; Sun L; Wen S; Tian Y; Xu C; Xu Q; Xue H
J Gene Med; 2024 Jan; 26(1):e3632. PubMed ID: 38282151
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of GRK6 associates with the progression and prognosis of colorectal carcinoma.
Tao R; Li Q; Gao X; Ma L
Oncol Lett; 2018 Apr; 15(4):5879-5886. PubMed ID: 29552218
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of stress-induced phosphoprotein 1 in colorectal cancer and its clinicopathologic significance.
Zhang Z; Ren H; Yang L; Zhang X; Liang W; Wu H; Huang L; Kang J; Xu J; Zhai E; Cai S; He Y
Hum Pathol; 2018 Sep; 79():135-143. PubMed ID: 29879402
[TBL] [Abstract][Full Text] [Related]
6. High expression of AMPD2 and obesity are associated with poor prognosis in colorectal cancer.
Wang F; Liu Y; Jiang J; Qin Y; Ge X; Li J; Qi X; Mao Y
Int J Clin Exp Pathol; 2018; 11(1):216-223. PubMed ID: 31938103
[TBL] [Abstract][Full Text] [Related]
7. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
[TBL] [Abstract][Full Text] [Related]
8. Association of long non-coding RNA HOTTIP with progression and prognosis in colorectal cancer.
Ren YK; Xiao Y; Wan XB; Zhao YZ; Li J; Li Y; Han GS; Chen XB; Zou QY; Wang GC; Lu CM; Xu YC; Wang YC
Int J Clin Exp Pathol; 2015; 8(9):11458-63. PubMed ID: 26617875
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance and Diagnostic Value of Overexpressed lncRNA PVT1 in Colorectal Cancer.
Pan X; Cheng R; Zhu X; Cai F; Zheng G; Li J; Gao C
Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850702
[TBL] [Abstract][Full Text] [Related]
10. CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study.
Huang F; Peng Y; Ye Q; Chen J; Li Y; Liu S; Xu Y; Huang L
World J Surg Oncol; 2020 Oct; 18(1):274. PubMed ID: 33099318
[TBL] [Abstract][Full Text] [Related]
11. Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage IV colorectal cancer.
Lee JL; Roh SA; Kim CW; Kwon YH; Ha YJ; Kim SK; Kim SY; Cho DH; Kim YS; Kim JC
World J Gastroenterol; 2019 Mar; 25(11):1341-1354. PubMed ID: 30918427
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of microRNA-126 is inversely correlated with insulin receptor substrate-1 protein expression in colorectal cancer and is associated with advanced stages of disease.
Ye S; Yu C; Zhang G; Shi F; Chen Y; Yang J; Wu W; Zhou Y
Oncol Lett; 2020 Sep; 20(3):2411-2419. PubMed ID: 32782558
[TBL] [Abstract][Full Text] [Related]
13. Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.
Shi H; Zhou Y; Liu H; Chen C; Li S; Li N; Li X; Zhang X; Zhang H; Wang W; Zhao Q
BMC Cancer; 2010 Sep; 10():477. PubMed ID: 20815902
[TBL] [Abstract][Full Text] [Related]
14. Expression of DNM3 is associated with good outcome in colorectal cancer.
Cheng SA; Huang X; Jiang L; Liang QL; Hong XC; Yang HX; Hu KH; Luo XB; Zhang HJ
Open Med (Wars); 2022; 17(1):221-226. PubMed ID: 35178475
[TBL] [Abstract][Full Text] [Related]
15. High NUCB2 expression level is associated with metastasis and may promote tumor progression in colorectal cancer.
Xie J; Chen L; Chen W
Oncol Lett; 2018 Jun; 15(6):9188-9194. PubMed ID: 29805650
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of lncRNA DANCR is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer.
Liu Y; Zhang M; Liang L; Li J; Chen YX
Int J Clin Exp Pathol; 2015; 8(9):11480-4. PubMed ID: 26617879
[TBL] [Abstract][Full Text] [Related]
17. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ
Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737
[TBL] [Abstract][Full Text] [Related]
18. Downregulated Tim-3 expression is responsible for the incidence and development of colorectal cancer.
Zhang P; Wang Y; Liu XR; Hong SR; Yao J
Oncol Lett; 2018 Jul; 16(1):1059-1066. PubMed ID: 29963183
[TBL] [Abstract][Full Text] [Related]
19. High expression of SLC17A9 correlates with poor prognosis in colorectal cancer.
Yang L; Chen Z; Xiong W; Ren H; Zhai E; Xu K; Yang H; Zhang Z; Ding L; He Y; Song X; Liu J
Hum Pathol; 2019 Feb; 84():62-70. PubMed ID: 30236596
[TBL] [Abstract][Full Text] [Related]
20. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.
Gao JY; Song BR; Peng JJ; Lu YM
World J Gastroenterol; 2012 Nov; 18(41):5965-71. PubMed ID: 23139614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
